The science and art of prostate cancer screening

Journal of the National Cancer Institute

Volumn 103, Issue 6, 2011, Pages 450-451

  Yao, Siu Long ^a,b   Lu Yao, Grace L ^a,c  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

^c UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; FINASTERIDE; PROSTATE SPECIFIC ANTIGEN;

BREAST CANCER; CANCER MORTALITY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SCREENING; CANCER SURGERY; CLINICAL DECISION MAKING; CLINICAL PRACTICE; COLORECTAL CANCER; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; DIGITAL RECTAL EXAMINATION; EDITORIAL; HUMAN; PHYSICIAN; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; RISK FACTOR; SCIENCE; UTERINE CERVIX CANCER;

BIOPSY; EARLY DETECTION OF CANCER; EUROPE; HUMANS; MALE; MASS SCREENING; META-ANALYSIS AS TOPIC; ODDS RATIO; PHYSICIAN'S PRACTICE PATTERNS; PREDICTIVE VALUE OF TESTS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL; UNITED STATES; UNNECESSARY PROCEDURES; VETERANS HEALTH;

EID: 79952855549     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djr047     Document Type: Editorial

References (17)

1. Schroder FH, Hugosson J, Roobol MJ, et al. Screening and prostate-cancer mortality in a randomized European study. N Engl J Med. 2009; 360(13):1320-1328.
2. Andriole GL, Crawford ED, Grubb RL III, et al. Mortality results from a randomized prostate-cancer screening trial. N Engl J Med. 2009;360(13): 1310-1319.
3. Zeliadt SB, Hoffman RM, Etzioni R, et al. Infuence of publications of US and European prostate cancer screening trials on PSA testing practices. J Natl Cancer Inst. 2011;103(6):520-523.
4. Majumdar SR, Almasi EA, Stafford RS. Promotion and prescribing of hormone therapy after report of harm by the Women's Health Initiative. JAMA. 2004;292(16):1983-1988. (Pubitemid 39411207)
5. Hakama M, Auvinen A. Cancer screening. In: Heggenhougen K, Quah SR, eds. International Encyclopedia of Public Health. San Diego, CA: Academic Press; 2008:464-480.
6. Draisma G, Boer R, Otto SJ, et al. Lead times and overdetection due to prostate-specifc antigen screening: estimates from the European randomized study of screening for prostate cancer. J Natl Cancer Inst. 2003;95(12): 868-878. (Pubitemid 36833878)
7. Roemeling S, Roobol MJ, de Vries SH, et al. Active surveillance for prostate cancers detected in three subsequent rounds of a screening trial: characteristics, PSA doubling times, and outcome. Eur Urol. 2007;51(5): 1244-1250; discussion 1251.
8. Shao YH, Albertsen PC, Roberts CB, et al. Risk profles and treatment patterns among men diagnosed as having prostate cancer and a prostate-specifc antigen level below 4.0 ng/ml. Arch Intern Med. 2010; 170(14):1256-1261.
9. Barry MJ. Screening for prostate cancer-the controversy that refuses to die. N Engl J Med. 2009;360(13):1351-1354.
10. AUA. Prostate-Specifc Antigen Best Practice Statement: 2009 Update. http://www.auanet.org/content/guidelines-and-quality-care/clinical-guidelines/ main-reports/psa09.pdf.
11. NCCN. Clinical Practice Guidelines in Oncology: Prostate Cancer Early Detection. 2010.
12. Prorok PC, Andriole GL, Bresalier RS, et al. Design of the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial. Control Clin Trials. 2000;21(6 suppl):273S-309S.
13. Schroder FH, Bangma CH. The European Randomized Study of Screening for Prostate Cancer (ERSPC). Br J Urol. 1997;79(suppl 1):68-71.
14. Vickers AJ, Till C, Tangen CM, Lilja M, Thompson IM. An empirical evaluation of guidelines on prostate specifc antigen velocity in prostate cancer detection. J Natl Cancer Inst. 2011;103(6):462-469.
15. Welch HG, Schwartz LM, Woloshin S. Prostate-specifc antigen levels in the United States: implications of various defnitions for abnormal. J Natl Cancer Inst. 2005;97(15):1132-1137. (Pubitemid 41511212)
16. Lu-Yao G, Stukel TA, Yao SL. Prostate-specifc antigen screening in elderly men. J Natl Cancer Inst. 2003;95(23):1792-1797. (Pubitemid 38008902)
17. Welch HG, Albertsen PC. Prostate cancer diagnosis and treatment after the introduction of prostate-specifc antigen screening: 1986-2005. J Natl Cancer Inst. 2009;101(19):1325-1329.